Cure Alzheimer's Fund Chairman and Co-Founder Jeff Morby and Co-Founder Jacqui Morby were featured for their support of Alzheimer's research in Sunday's Pittsburgh Post-Gazette. The article highlights Cure Alzheimer's Fund's success and the commitment of its founders and board to cover all operating costs. The Post-Gazette also describes the origins of the fund, which started off under the Pittsburgh Foundation until the Morbys garnered enough support to launch a public charity.
Ten years ago, our founders started Cure Alzheimer's Fund out of frustration with the slow pace and limited funding of research. Since then, we've funded dozens of ground-breaking studies that have enhanced our understanding of Alzheimer's disease and brought us closer to a cure.
Several weeks ago, the Cure Alzheimer’s Fund (CAF) Executive Committee and staff met with the members of our Research Consortium in Chicago.
On May 18 Jeff Morby, chairman and co-founder of Cure Alzheimer’s Fund, was honored with the prestigious Paul Harris Award from Rotary District 7950. Paul Harris founded the Rotary Club more than a century ago and the award was created to recognize those who have made great contributions to society under the Rotary’s motto of “Service Above Self.”
Henry McCance, chairman emeritus of Greylock Partners, co-founded Cure Alzheimer’s Fund (CAF) in 2005 after getting frustrated with the lack of knowledge about the disease when his wife was diagnosed. He was interviewed by the Boston Business Journal about his venture capital approach to funding Alzheimer's disease research.
Over the last several days, two important announcements pertaining to Alzheimer's and other neurological diseases have been made.
A Pittsburgh philanthropist and retired Mellon exec thinks so. In 1988, Jeffrey L. Morby left American Express to join the management team tapped to rescue the nearly bankrupt Mellon Bank. After helping turn Mellon around, he retired at 59, but Morby has hardly been wiling away the time.
From our 2011 Annual Report.
On behalf of the Board of Directors and the Research Consortium, we want to thank all the donors, researchers and academic institutional partners supporting Cure Alzheimer’s Fund research for your help in making 2011 such a successful science year. Guided by leading scientists in the field, Cure Alzheimer’s Fund-supported research continues to make breakthrough progress toward our goal of eradicating Alzheimer’s disease.
Our focus on funding high-quality, innovative work is fueling progress in Alzheimer’s research
It has been an outstanding year at Cure Alzheimer’s Fund(CAF). Our strategy of using a business and venture approach for funding research is working. We’ve been recognized in The Wall Street Journal, Time magazine and AARP, featured on NPR and CNN.com and invited to exclusive conferences at the White House, TEDMED and the Milken Institute.
Why should you care about Alzheimer’s research?
Currently, for every dollar spent on Alzheimer’s care, only a penny is spent working toward a cure. This is a bad equation for a disease that is estimated will cost well more than $100 billion in care (Medicare and Medicaid alone) in 2009.
© 2005-2015 Cure Alzheimer's Fund. All rights reserved.